| Primary |
| Product Used For Unknown Indication |
54.2% |
| Schizophrenia |
10.1% |
| Bipolar Disorder |
7.1% |
| Schizoaffective Disorder |
6.3% |
| Psychotic Disorder |
3.8% |
| Bipolar I Disorder |
3.6% |
| Depression |
2.3% |
| Anxiety |
2.2% |
| Schizophrenia, Paranoid Type |
2.2% |
| Diabetes Mellitus |
1.1% |
| Affective Disorder |
0.9% |
| Insomnia |
0.9% |
| Major Depression |
0.9% |
| Bipolar Ii Disorder |
0.7% |
| Mood Swings |
0.7% |
| Pain |
0.7% |
| Hypertension |
0.6% |
| Paranoia |
0.6% |
| Post-traumatic Stress Disorder |
0.6% |
| Type 1 Diabetes Mellitus |
0.6% |
|
| Urticaria |
9.9% |
| Death |
7.7% |
| Weight Increased |
7.0% |
| Rash |
6.3% |
| Hypersensitivity |
5.6% |
| Vomiting |
5.6% |
| Anaphylactic Reaction |
4.9% |
| Oedema Peripheral |
4.9% |
| Pregnancy |
4.9% |
| Swollen Tongue |
4.9% |
| Angioedema |
4.2% |
| Drug Ineffective |
4.2% |
| Feeling Abnormal |
4.2% |
| Psychiatric Decompensation |
4.2% |
| Psychotic Disorder |
4.2% |
| Aggression |
3.5% |
| Serotonin Syndrome |
3.5% |
| Suicide Attempt |
3.5% |
| Weight Decreased |
3.5% |
| Homicidal Ideation |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
44.8% |
| Schizophrenia |
9.3% |
| Bipolar Disorder |
7.7% |
| Bipolar I Disorder |
6.2% |
| Anxiety |
5.9% |
| Schizoaffective Disorder |
5.4% |
| Major Depression |
3.4% |
| Depression |
3.1% |
| Psychotic Disorder |
2.9% |
| Schizophrenia, Paranoid Type |
1.6% |
| Paranoia |
1.4% |
| Dermal Cyst |
1.2% |
| Affective Disorder |
1.0% |
| Insomnia |
1.0% |
| Attention Deficit/hyperactivity Disorder |
0.9% |
| Hallucination |
0.9% |
| Psychiatric Decompensation |
0.9% |
| Diabetes Mellitus |
0.8% |
| Mood Swings |
0.8% |
| Asthma |
0.7% |
|
| Weight Increased |
11.4% |
| Vomiting |
10.0% |
| Death |
8.6% |
| Completed Suicide |
7.9% |
| Insomnia |
7.1% |
| Serotonin Syndrome |
7.1% |
| Urticaria |
5.0% |
| Angioedema |
4.3% |
| Tremor |
4.3% |
| Oedema Peripheral |
3.6% |
| Psychiatric Decompensation |
3.6% |
| Psychotic Disorder |
3.6% |
| Schizophrenia |
3.6% |
| Sexual Dysfunction |
3.6% |
| Dizziness |
2.9% |
| Pregnancy |
2.9% |
| Pyrexia |
2.9% |
| Restlessness |
2.9% |
| Vision Blurred |
2.9% |
| Anxiety |
2.1% |
|
| Concomitant |
| Bipolar Disorder |
19.2% |
| Depression |
14.4% |
| Product Used For Unknown Indication |
10.9% |
| Schizophrenia |
8.6% |
| Generalised Anxiety Disorder |
6.8% |
| Gastrooesophageal Reflux Disease |
5.1% |
| Anxiety |
4.0% |
| Schizoaffective Disorder |
4.0% |
| Pain |
3.8% |
| Sleep Disorder |
3.5% |
| Hypertension |
3.3% |
| Psychiatric Symptom |
2.5% |
| Hepatitis C |
2.3% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Bipolar I Disorder |
1.8% |
| Insomnia |
1.8% |
| Blood Pressure |
1.5% |
| Convulsion |
1.5% |
| Fibromyalgia |
1.5% |
| Hypersensitivity |
1.5% |
|
| Weight Increased |
12.9% |
| Stress Fracture |
9.7% |
| Granulocytopenia |
8.1% |
| Tremor |
6.5% |
| Back Pain |
4.8% |
| Drug Ineffective |
4.8% |
| Injection Site Swelling |
4.8% |
| Leukopenia |
4.8% |
| Plantar Fasciitis |
4.8% |
| Psychotic Disorder |
4.8% |
| Somnolence |
4.8% |
| Convulsion |
3.2% |
| Depression |
3.2% |
| Fatigue |
3.2% |
| Feeling Abnormal |
3.2% |
| Malaise |
3.2% |
| No Adverse Event |
3.2% |
| Off Label Use |
3.2% |
| Overdose |
3.2% |
| Pain In Extremity |
3.2% |
|
| Interacting |
| Bipolar Ii Disorder |
75.0% |
| Bipolar Disorder |
25.0% |
|
| Psychomotor Hyperactivity |
75.0% |
| Drug Interaction |
25.0% |
|
